AzTrials
AzTrials

Low Back PainPEMS-CLBPNCT07243548

Effect of Peripheral Magnetic Stimulation in Patients With Chronic Lower Back Pain

A study testing rPMS Intervention in people with Low Back Pain, run by Inês Gomes at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to analyze the effect of Repeated Peripheral Magnetic Stimulation (rPMS) in patients with chronic low back pain. This is a controlled, randomized, multicenter clinical trial (Brazil x Portugal). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Low Back Pain
What is being tested?
rPMS Intervention
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 sitePortugal
Study dates
1 May 2025to 27 Nov 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals with complaints of low back pain for more than three months
  • Non-practitioners of sports activities
  • Absence of significant spinal pathologies, such as previous history of myelopathies, surgeries, instabilities, or deformities (bone fractures)
  • Normal neurological examination for radiculopathies (patellar and Achilles tendon reflexes, voluntary motor function, and sensitivity test)

Who cannot join

  • Presence of trauma or systemic dysfunction
  • Use of other alternative treatments
  • Refusal to be randomized
  • Protrusion or prolapse of one or more intervertebral discs with neurological symptoms
  • Previous spinal surgery
  • Infectious spondylopathy
Show all 12Show fewer
  • Low back pain secondary to inflammation, tumor, or autoimmune disease
  • Congenital spinal deformities
  • Compression fracture caused by osteoporosis, spondylolysis, or spondylolisthesis
  • Use of prosthesis
  • History of seizures or epilepsy
  • Implanted or non-removable intracranial metal or devices

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Egas Moniz School of Health and Science

    Almada, Setúbal District, 2829 - 511

Other trials in Portugal

About this study

Official title: Effect of Peripheral Magnetic Stimulation in Patients With Chronic Lower Back Pain - Controlled, Randomized Clinical Trial

The aim of this study is to analyze the effect of Repeated Peripheral Magnetic Stimulation (rPMS) in patients with chronic low back pain. This is a controlled, randomized, multicenter clinical trial (Brazil x Portugal). The sample will consist of individuals with chronic low back pain with a score between 40 and 80 on the Oswestry scale, who will be randomly divided into 2 groups: control (CG) and intervention (IG). The instruments used for evaluation will be: visual analog pain scale (VAS), brief pain inventory (BPI), McGill questionnaire, Roland Morris scale and WHOQOL-BREF. Both groups will use the EMP device, with 10 sessions over a period of 2 weeks, in the IG applied in the flat tangential orientation lasting 20 minutes and an intermittent stimulation protocol consisting of 5 seconds of stimulation at a frequency of 20 Hz followed by 25 seconds of rest with a minimum intensity of 20% up to the maximum intensity to induce sufficient contraction of the paraspinal muscle and in the CG in transverse orientation with the stimulus intensity level set at 5% of the maximum output of the stimulator to minimize stimulation, both in the most painful lumbar region. The Wilcoxon test will be applied. Then, the Mann-Whitney test will be applied, adopting a significance level of 5%. It is expected that this research will contribute to more accurate protocols and evaluation methods for the EMP intervention, which generates responses in pain relief and non-surgical treatment.

Read the detailed description

Low back pain is one of the most disabling and therapeutically challenging conditions affecting the population. Chronic low back pain is defined as pain and discomfort located below the rib margins and above the gluteal line, with or without pain referred to the lower limbs and represents a considerable challenge in terms of public health, with high financial costs. In Brazil, approximately 10 million Brazilians become disabled by this morbidity and at least 70% of the population will suffer an episode of low back pain in their lifetime.

In young adults, there are numerous studies on the impact of low back pain on functionality and therapeutic interventions, largely due to the high costs to the health service caused by the disability resulting from chronic low back pain in this economically active population. However, despite being identified as an important health problem, its consequences, as well as the effectiveness of therapeutic programs, are little known among the population.

Repetitive peripheral magnetic stimulation (rPMS) is a clinical treatment modality that depends on the generation of a powerful magnetic field by means of an electromagnetic coil. It is a low-intensity current capable of producing electrical impulses with variable frequencies of up to 200 Hz, thus being effective in the treatment of musculoskeletal pain, modeling and influencing pain neuroconduction processes. This electrical stimulation is capable of reducing pain through peripheral stimulation of large diameter fibers (A fibers), ending up inhibiting the entry of painful stimuli conducted by narrow diameter fibers (A delta and C fibers) closing the pain gate.

rPMS increases the cortical-motor excitability of the areas to be stimulated. This stimulation facilitates neuroplastic changes that improve motor recovery in the long term. Its beneficial effects on patients include increased muscle strength and mobility, decreased spasticity, analgesia, reduced edema, vasodilation, and decreased reflex inhibition, among others. However, to the best of our knowledge, no study has investigated the synergistic effects of SMP in patients with chronic low back pain with scores between 40 and 80 on the Oswestry scale. Therefore, it is extremely important to search for effective treatment modalities to improve pain and associated functional disability for the treatment of these patients.

OBJECTIVE General Objective To investigate the effects of rPMS treatment compared to a placebo treatment with the same equipment in reducing pain and functionality in patients with chronic low back pain.

Specific Objectives To verify whether rPMS alters the analgesic perception in the VAS, MPQ and BPI in patients with chronic low back pain; To verify whether rPMS alters the functionality of the lumbar spine by the ODI, RMDQ and WHOQOL-BREF in patients with chronic low back pain.

JUSTIFICATION Peripheral magnetic stimulation is a method indicated in the treatment of neuropathic pain syndromes, together with other forms of neurostimulation: electrical stimulation of the dorsal spine and deep brain stimulation. It is capable of bringing several benefits to patients, with an associated form of applicability and there are still few studies in patients with chronic low back pain, the application of this technique is justified to verify these effects in these patients. a modality.

METHODOLOGY Study design A controlled, randomized, multicenter clinical study will be conducted. Study location and population The study will be conducted at the Physiotherapy School Clinic of the Federal University of Alfenas (MG/Brazil), at the Neuroscience, Neuromodulation and Pain Study Laboratory - LANNED, located in the municipality of Alfenas, Minas Gerais, and at the Egas Moniz School of Health and Science (Portugal), at the Neuromodulation and Pain Unit - NeuroPain, in the municipality of Almada, Setúbal.

Sample Individuals with chronic low back pain with a score between 40 and 80 on the Oswestry scale will be selected, and 40 will be selected for treatment at the Physiotherapy School Clinic of the Federal University of Alfenas - MG and the Egas Moniz University Clinic - CUEM. The individuals will be divided into 2 groups: the control group and the intervention group.

Inclusion criteria The inclusion criteria considered: individuals with complaints of low back pain for more than three months, non-practitioners of sports activities, absence of significant spinal pathologies such as previous history of myelopathies, surgeries, instability or deformities in the spine (bone fractures), normal neurological examination for radiculopathies (patellar and Achilles tendon reflexes; voluntary motor function; sensitivity test).

Exclusion criteria The exclusion criteria are: trauma or systemic dysfunction; use of other alternative treatments; refusal to be randomized; protrusion or prolapse of one or more intervertebral discs with neurological symptoms; previous spinal surgery; infectious spondylopathy; low back pain secondary to inflammation, tumor or autoimmune disease; congenital spinal deformities; compression fracture caused by osteoporosis, spondylolysis or spondylolisthesis. Individuals who use prostheses; who have a history of seizures; have a history of epilepsy and have implanted or non-removable intracranial metal or devices.

Randomization of samples:

The volunteers will be divided into a control group and an intervention group through randomization. To do this, the participants will be allocated by another researcher, who will use the Research Randomizer website into two groups: Control Group (CG) and Intervention Group (IG).

Sample calculation The sample calculation performed estimates the number of 15 volunteers per group. This calculation will be performed to ensure a statistical power of 85% (β=0.20) and a significance level when p= 0.05.

Assessment Instruments:

Visual Analogue Scale (VAS) The VAS is a scale similar to a ruler, numbered with a starting point of zero and an ending point of ten, with 0 being no pain and 10 being the most unbearable pain felt at that moment by the patient.

The VAS was used to quantify the intensity and perception of the individual's pain, graded according to ordinal scores: no pain (0), mild pain (1 to 2), moderate (3 to 5) and severe (6 to 10).

Pressure Pain Threshold (PPT) PPTs will be assessed using a portable pressure algometer with a 1 cm2 rubber tip applicator and Bluetooth communication interface, placed perpendicularly on the skin with an application rate of 0 to 15 kgf/s (Physiocode brand). PPT will be defined as the minimum pressure first evoking a sensation of pain. PPTs will be measured twice with an interval of 10 seconds for each point, and the average value will be used for statistical analysis.

Algometry was used to examine the pain threshold for pressure applied between the spinous processes of the lumbar spine L1-L5.

McGill Pain Questionnaire (MPQ) The McGill Pain Questionnaire, also used to assess pain, is an instrument consisting of 78 descriptors (words that describe pain), organized into four categories (sensory, affective, evaluative, and mixed) and 20 subcategories. The individual is asked to choose one word from each subcategory, allowing the option of not choosing any. The analysis is performed by categories by adding the values associated with the chosen words and from the words selected by more than 30% of the population surveyed. Furthermore, this questionnaire is important for assessing pain from a multidimensional perspective, understanding that its development was based on the theoretical framework of pain physiology, which presupposes some universality of pain qualities and, finally, studies that confirmed that individuals with different sociocultural backgrounds, but with similar symptoms.

Brief Pain Inventory (BPI) Brief Pain Inventory - short form (Brief Pain Inventory - BPI): Multidimensional instrument that uses a scale of 0-10 to grade the following items: intensity, pain interference in the patient's ability to walk, daily activities, work, social activities, mood and sleep. The pain assessed by the patient is that experienced at the time of the questionnaire and the most intense, the least intense and the average pain of the last 24 hours.

Oswestry Scale (ODI) The Oswestry Scale (The Oswestry Disability Index, ODI) is a disease-specific instrument recommended for the assessment of spinal disorders. The ODI is an ordinal instrument, where 10 criteria are analyzed with six response alternatives for each criterion. The total score ranges from 0 to 100, with zero corresponding to normal function and 100 indicating great disability. For each item, zero is normality and five is the greatest functional alteration. The sum of the 10 questions divided by five multiplied by the number of questions answered, and multiplying everything by 100, constitutes the ODI.

Roland Morris Questionnaire (RMDQ) The Roland-Morris Brazil questionnaire (from the English and Roland Morris disability questionnaire, RMDQ) is specific to measure the functional disability of patients with low back pain, and consists of 24 questions related to activities of daily living, pain and function. For each affirmative question, 1 point is assigned. The score is the sum of the values, with a minimum score of "0" and a maximum score of "24". This questionnaire has a cut-off point of "14", that is, individuals evaluated with a score equal to or greater than "14" are classified as functionally disabled. Quality of life assessment instrument, abbreviated version (WHOQOL-BREF) The quality of life assessment instrument (WHOQOL-100) developed by the WHO Quality of Life Group in its abbreviated version (World Health Organization Quality of Life Bref, WHOQOL-BREF) will be used. This questionnaire consists of 26 questions (with questions 1 and 2 about general quality of life), and the answers follow a Likert scale (from 1 to 5, the higher the score, the better the quality of life). In addition to these two questions (1 and 2), the instrument has 24 facets that make up 4 domains: physical, psychological, social relationships and environment. Repeated Peripheral Magnetic Stimulation (rRPMS) Both groups will use the rRPMS device, with 10 sessions over a period of 2 weeks, in the IG applied in a flat tangential orientation lasting 20 minutes and an intermittent stimulation protocol consisting of 5 seconds of stimulation at a frequency of 20 Hz followed by 25 seconds of rest with a minimum intensity of 20% up to maximum intensity to induce sufficient contraction of the paraspinal muscle and in the CG in a transverse orientation with the stimulus intensity level set at 5% of the maximum output of the stimulator to minimize stimulation, both in the most painful lumbar region.

The group will be randomized into IG (n=25) and CG (n=25). It is known that a round coil is more advantageous than a figure-8 coil for stimulating structures in a deep layer such as spinal roots and covering a larger area such as a paravertebral muscle group. Thus, the investigators will use the round coil that will be more suitable for the treatment of low back pain.

The stimulation site will be determined based on the patient's most sensitive point before the start of each treatment session. For patients in the rPMS intervention group - in the prone position - the coil will be placed in a flat tangential orientation targeting the most painful lumbar region. This will allow the coil to be positioned parallel to the body surface, thus maximizing the effects of the magnetic stimulation applied to the area.

For patients in the rPMS control group, also in the prone position, the coil will be applied in a transverse orientation to the most painful lumbar region. This position of the coil, at a 90° angle to the body surface, will minimize the effects of magnetic stimulation applied to the area.

Both groups will undergo 10 sessions over a 2-week period. Each session will last 20 minutes and will use an intermittent stimulation protocol consisting of 5 seconds of stimulation at a frequency of 20 Hz followed by 25 seconds of rest. The total number of stimuli over 20 minutes will be 4,000 pulses.

The stimulation intensity level will be set at the level that induces sufficient contraction of the paraspinal muscle while still within the patient's tolerable range. For the rRPMS control group, the stimulus intensity level will be set at 5% of the maximum output of the stimulator to minimize magnetic stimulation.

Both groups will be exposed to an identical clicking sound generated during each session and the coil will be placed in contact with the patient (to have a similar sensation). The application of the rRPMS coil in both groups of patients will be conducted by experienced physiotherapists with sufficient preliminary training on the application of rPMS prior to the study.

Ethical Aspects

This project was submitted to the Ethics Committee of the Federal University of Alfenas for evaluation, and will comply with the precepts contained in resolution 466/12 of the National Health Council. It will also be submitted to the Egas Moniz Ethics Committee. Before starting to participate in this research, volunteers will receive all information related to the objectives and methodological procedures of the study and, after agreeing to participate, will sign the informed consent form. Participants will be informed about the objectives, research procedures, risks, benefits and minimization measures, and the data will be presented together. The informant may withdraw his/her participation at any time.

Statistical Procedures The Wilcoxon test will be used to assess possible differences between the results before and after the application of the treatment protocol in each group. The Mann-Whitney test will be used to assess the difference between the groups. A significance level of 0.05 will be adopted.

EXPECTED RESULTS It is expected that this research will contribute to more accurate protocols and evaluation methods for intervention with peripheral magnetic stimulation in chronic pain, as well as scientific basis for the technique.

RISKS AND BENEFITS:

The application of any therapeutic resource may expose the participant to some type of risk, however, this research is designed to minimize this occurrence as much as possible. Since it is an electromagnetic stimulation, the participant may feel some discomfort or pain, so he/she can end his/her participation immediately without any burden. It is expected that after the intervention of this research, it will bring benefits in improving chronic low back pain.

SANITARY MEASURES

Sanitary measures will be taken for both patients and researchers:

Exposure to sources of infection will be controlled, which is extremely important to protect patients and researchers and, thus, prevent outbreaks within the institution.

All health service professionals must wear face masks (surgical or N95/PFF2 or equivalent) for personal protection and source control (GVIMS/GGTES/ANVISA No. 07/2020); in addition, patients must wear the same mask.

Avoid close contact with people (i.e., maintain a distance of at least one meter), especially with those who have a fever, cough or sneezing; Practice respiratory etiquette (i.e., cover your mouth and nose with your forearm when coughing or sneezing with disposable tissues, discard them immediately after use in a closed trash can, and then sanitize your hands).

Wash your hands frequently with soap and water or with a 70% alcohol-based hand sanitizer and avoid touching your eyes, nose, and mouth with unwashed hands; It is known that viruses are inactivated by 70% alcohol and chlorine. Therefore, disinfect the surfaces of the location frequently.

Conditions
Low Back Pain
Being tested
rPMS Intervention, rPMS Controle
Keywords
Peripheral magnetic stimulation, low back pain, chronic pain, neuromodulation
Medical subject headings
Low Back Pain, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • rPMS InterventionDevice

    Both groups will undergo 10 sessions over a 2-week period. Each session will last 20 minutes and will be intermittent stimulation protocol consisting of 5 seconds of stimulation at a frequency of 20 Hz followed by 25 seconds of rest. The total number of stimulations over 20 minutes will be 4,000 pulses.

    The stimulation intensity level will be set at the level that induces sufficient contraction of the paraspinal muscle while still within the tolerable range of the patient. For the rRPMS control group, the stimulus intensity level will be set at 5% of the maximum output of the stimulator to minimize magnetic stimulation.

    Both groups will be exposed to an identical clicking sound generated during each session and the coil will be placed in contact with the patient (to have a similar sensation). The application of the rRPMS coil in both groups of patients will be conducted by experienced physiotherapists with sufficient preliminary training on the application of rPMS prior to the study.

  • rPMS ControleDevice

    Both groups will undergo 10 sessions over a 2-week period. Each session will last 20 minutes and will be intermittent stimulation protocol consisting of 5 seconds of stimulation at a frequency of 20 Hz followed by 25 seconds of rest. The total number of stimulations over 20 minutes will be 4,000 pulses.

    The stimulation intensity level will be set at the level that induces sufficient contraction of the paraspinal muscle while still within the tolerable range of the patient. For the rRPMS control group, the stimulus intensity level will be set at 5% of the maximum output of the stimulator to minimize magnetic stimulation.

    Both groups will be exposed to an identical clicking sound generated during each session and the coil will be placed in contact with the patient (to have a similar sensation). The application of the rRPMS coil in both groups of patients will be conducted by experienced physiotherapists with sufficient preliminary training on the application of rPMS prior to the study.

Study groups in NCT07243548
Study groupRoleWhat they receive
rPMS ControleExperimentalFor patients in the rPMS control group, also in the prone position, the coil will be applied in a transverse orientation to the most painful lumbar region. This position of the coil, at a 90° angle to the body surface, will minimize the effects of the magnetic stimulation applied to the area.
Receives: Device: rPMS Controle
rPMS InterventionExperimentalFor patients in the rPMS intervention group - in the prone position - the coil will be placed in a flat tangential orientation targeting the most painful lumbar region. This will allow the coil to be positioned parallel to the body surface, thus maximizing the effects of the magnetic stimulation applied to the area.
Receives: Device: rPMS Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oswestry Disability Index (ODI)

    Disease-specific questionnaire measuring functional disability (0=no disability, 100=complete disability)

    Measured: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)

Secondary outcomes (7)
  1. Pain Intensity at Rest (VAS)

    Visual Analogue Scale for pain at rest (0=no pain, 10=worst pain)

    Measured: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)

  2. Pain Intensity During Activity (VAS)

    Visual Analogue Scale for pain during physical activity (0=no pain, 10=worst pain)

    Measured: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)

  3. Pressure Pain Threshold Right Lumbar Region

    Algometry (1 cm² tip) over lumbar spinous processes L1-L5 (right), minimum pressure for first pain sensation (mean of 2 trials)

    Measured: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)

  4. Pressure Pain Threshold Left Lumbar Region

    Algometry (1 cm² tip) over lumbar spinous processes L1-L5 (right), minimum pressure for first pain sensation (mean of 2 trials)

    Measured: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)

  5. Lumbar Mobility (Schober Test)

    Increase in skin distance (cm) during forward flexion

    Measured: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)

  6. Oswestry Disability Category

    Categorical score derived from ODI (0=no disability to 5=bedbound)

    Measured: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)

  7. Physical Activity Level (IPAQ)

    International Physical Activity Questionnaire category (0=sedentary, 1=physically active)

    Measured: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2025
  2. Study start1 May 2025
  3. Primary completion1 Nov 2025
  4. Study completion27 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Individuals with chronic low back pain with a score between 40 and 80 on the Oswestry scale will be selected, and 40 will be selected for treatment at the Physiotherapy School of the Federal University of Alfenas - MG and the Egas Moniz University Clinic - CUEM. The individuals will be divided into 2 groups: the control group and the intervention group. The volunteers will be divided into a control group and an intervention group through randomization. To this end, the participants will be allocated by another researcher, who will use the Research Randomizer website into two groups: Control Group (CG) and Intervention Group (IG).
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07243548
Sponsor's protocol ID
CEEM1329
Acronym
PEMS-CLBP
Status last verified
Dec 2025
First submitted
16 Apr 2025
Last updated
25 Feb 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The individual participant data (IPD) from this study will not be shared due to ethical and privacy concerns. The collected information includes sensitive health data that, even if anonymized, could potentially lead to the identification of participants, especially given the relatively small sample size and the specific nature of the intervention. Furthermore, the informed consent obtained from participants does not include provisions for public data sharing.

Publications

  • Lim YH, Song JM, Choi EH, Lee JW. Effects of Repetitive Peripheral Magnetic Stimulation on Patients With Acute Low Back Pain: A Pilot Study. Ann Rehabil Med. 2018 Apr;42(2):229-238. doi: 10.5535/arm.2018.42.2.229. Epub 2018 Apr 30.

    PubMed 29765876
  • Masse-Alarie H, Beaulieu LD, Preuss R, Schneider C. Repetitive peripheral magnetic neurostimulation of multifidus muscles combined with motor training influences spine motor control and chronic low back pain. Clin Neurophysiol. 2017 Mar;128(3):442-453. doi: 10.1016/j.clinph.2016.12.020. Epub 2016 Dec 28.

    PubMed 28160750
  • Diao Y, Pan J, Xie Y, Liao M, Wu D, Liu H, Liao L. Effect of Repetitive Peripheral Magnetic Stimulation on Patients With Low Back Pain: A Meta-analysis of Randomized Controlled Trials. Arch Phys Med Rehabil. 2023 Sep;104(9):1526-1538. doi: 10.1016/j.apmr.2023.03.016. Epub 2023 Apr 26.

    PubMed 37116558

Questions about this trial

What is this clinical trial studying?

A study testing rPMS Intervention in people with Low Back Pain, run by Inês Gomes at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 25 Feb 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oswestry Disability Index (ODI) (time frame: Baseline and immediately post-treatment (after 10 sessions over 2 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07243548, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in